PREMAL LULLA to Hematologic Neoplasms
This is a "connection" page, showing publications PREMAL LULLA has written about Hematologic Neoplasms.
Connection Strength
0.879
-
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice. Hum Vaccin Immunother. 2024 12 31; 20(1):2378543.
Score: 0.723
-
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
Score: 0.156